Evaluation of Beauvericin’s activity and mode of action against all life stages of L. tropica for cutaneous Leishmaniasis therapy
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1599766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Lynn Al Samra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Chouran, Beirut, Lebanon. Hauptthemen laut MEDLINE: Leishmania tropica, Leishmaniasis, Cutaneous, Antiprotozoal Agents, Depsipeptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Leishmaniasis, particularly its cutaneous form caused by Leishmania tropica , remains a significant global health concern due to the limitations of current treatments, including drug resistance, toxicity, and inconsistent efficacy. This study investigates the potential of Beauvericin (BEA), a fungal secondary metabolite, as an alternative antileishmanial agent.
Objectives
This study investigates the potential of Beauvericin (BEA), a fungal secondary metabolite, as an alternative antileishmanial agent.
Methods
We assessed the efficacy of BEA against different developmental stages of L. tropica using in vitro assays and an in vivo Galleria mellonella infection model. The ability of L. tropica to develop resistance to BEA and its effects on the parasite’s gene expression profile were also examined.
Results
BEA exhibited potent antileishmanial activity with equipotency across both promastigote and amastigote stages of L. tropica , with IC 50 values of 0.25 µM and 0.27 µM, respectively, significantly lower than those of miltefosine. Mechanistically, BEA acts as a calcium ionophore, inducing a marked increase in intracellular calcium levels, which serves as the primary cytotoxic event. Transcriptomic profiling further revealed that BEA-induced calcium dysregulation triggers secondary cellular responses involving calcium homeostasis, lipid metabolism, and stress response, contributing to its multifaceted mechanism of action. The G. mellonella model demonstrated that BEA significantly reduced parasite burden, improved survival rates. Notably, BEA showed a slower rate of resistance development compared to ML, indicating its potential as a more sustainable treatment option.
Conclusions
BEA is a promising candidate for antileishmanial therapy, demonstrating superior efficacy, a broad mechanism of action, and a favorable resistance profile compared to ML. Further investigations in mammalian models are warranted to validate BEA’s potential as a novel, cost-effective treatment for leishmaniasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Chouran, Beirut, Lebanon.
- Department of Computer Science and Mathematics, Lebanese American University, Beirut, Lebanon.
- Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Byblos, Lebanon.
- Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon.
- Department of Plant Protection, Faculty of Agricultural & Veterinary Sciences, Lebanese University, Dekwaneh, Beirut, Lebanon.
Zitieren
APA
Al Samra, L., El Nahas, M., Mneimneh, I., Sinno, A., Tokajian, S., Rahy, K., Thoumi, S., Ali, L., Yammine, W., & Al Khoury, C. (2025). Evaluation of Beauvericin’s activity and mode of action against all life stages of L. tropica for cutaneous Leishmaniasis therapy. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1599766
Vancouver
Al Samra L, El Nahas M, Mneimneh I, Sinno A, Tokajian S, Rahy K, et al. Evaluation of Beauvericin’s activity and mode of action against all life stages of L. tropica for cutaneous Leishmaniasis therapy. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1599766
BibTeX
@article{AlSamra2025,
author = {Al Samra, Lynn and El Nahas, Mohamad and Mneimneh, Ilham and Sinno, Aia and Tokajian, Sima and Rahy, Kelven and Thoumi, Sergio and Ali, Lazo and Yammine, Wael and Al Khoury, Charbel},
title = {Evaluation of Beauvericin’s activity and mode of action against all life stages of L. tropica for cutaneous Leishmaniasis therapy},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1599766}
}
EUVIMED